Annual cost of ischemic heart disease in Brazil. Public and private perspective;Custo anual do manejo da cardiopatia isquêmica crônica no Brasil. Perspectiva pública e privada

Arquivos Brasileiros de Cardiologia

Volumn 85, Issue 1, 2005, Pages 3-8

  Ribeiro, Rodrigo Antonini ^a,b   Mello, Renato G B ^a   Melchior, Raquel ^a   Dill, Juliana C ^a   Hohmann, Clarissa B ^a   Lucchese, Angélica M ^a   Stein, Ricardo ^a   Ribeiro, Jorge Pinto ^a   Polanczyk, Carisi A ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b NONE   (Brazil)

Author keywords

Cohort; Coronary artery disease; Cost of illness; Economical analysis

Indexed keywords

ACUTE HEART INFARCTION; BRAZIL; COHORT ANALYSIS; CORONARY ARTERY DISEASE; COST OF ILLNESS; DIABETES MELLITUS; FEMALE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH MAINTENANCE ORGANIZATION; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; REIMBURSEMENT; REVIEW;

BRAZIL; COHORT STUDIES; FEMALE; HEALTH CARE COSTS; HEALTH MAINTENANCE ORGANIZATIONS; HOSPITALIZATION; HUMANS; MALE; MYOCARDIAL ISCHEMIA; NATIONAL HEALTH PROGRAMS; PRIVATE SECTOR; PUBLIC SECTOR;

EID: 22644443087     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Mansur AP, Souza MFM, Timerman A, Ramires JAF. Tendência do risco de morte por doenças circulatórias, cerebrovascularese isquêmicas do coração em 11 capitais do Brasil, de 1980 a 1998. Arq Bras Cardiol 2002; 79: 269-76.
2. Russell MW, Huse DM, Drowns S, Hamel EC, Hartz SC. Direct medical costs of coronary artery disease in the United States. Am J Cardiol 1998; 81: 1110-5.
3. Stewart S, Murphy N, Walker A, McGuire A, McMurray JJ. The Current Cost of Angina Pectoris to the National Health Service in the UK. Heart 2003; 89: 848-53.
4. Pithan CF, Fay CES, Souza FB et al. Preditores de eventos cardíacos maiores em pacientes com cardiopatia isquêmica estável. In: XIII Congresso de Cardiologia do Rio Grande do Sul, 2002, Gramado. Anais do XIII Congresso de Cardiologia do Rio Grande do Sul, 2002.
5. Stein R, Tochetto E, Alboim C et al. Tratamento farmacológico da cardiopatia isquêmica: qual o custo e quais estratégias para reduzí-lo? Arq Bras Cardiol 2001; 78: 96.
6. Stein R, Alboim C, Campos C, Mello RB, Rosito GA, Polanczyk CA. Variabilidade entre cardiologistas na abordagem aos pacientes em prevenção secundária da cardiopatia isquêmica. Arq Bras Cardiol 2004; 83: 219-222.
7. http://www.calcmed.com.br/tabelasnet/tabelas_convenios.asp, acessado em 30/06/2004.
8. World Health. The World Health Report 2000: Health systems: improving performance. Geneva: World Health Organization; 2000.
9. http://www3.who.int/whosis/cea/prices/ppp.cfm, acessado em 28/09/2004.
10. Mowatt G, Vale L, Brazzelli M et al. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. Health Technol Assess. 2004 Jul; 8(30): iii-iv, 1-207.